Because of their link to disease, all major pharmaceutical and biotechnology companies have active drug discovery programs based on understanding signal transduction pathways. Table 1 lists ...

The Food and Drug Administration is projecting a more favorable stance toward biotech, emphasizing streamlined processes and accelerated approvals (“FDA Sends a Bullish Signal to Biotech ...